Table 1. Summary information on the four included studies.
Reference | Study design:
Outcome measure |
Inclusion criteria (No. of
patients) |
Duration of
follow up |
Adjustment for
confounders |
NOQAS Score
(max = 9) |
---|---|---|---|---|---|
Azuma et al. 1982 | Case report:
Clinical signs and symptoms of CHF and NYHA class. |
CHF patients due to MVD (n=7). | 4 weeks | No comparison | 3 |
Azuma et al. 1985 | Cohort:
HF severity, electrocardiogram, phonocardiogram, carotid arterial pulse tracing, NYHA class, clinical manifestation. |
CHF patients (n=14; 8 IHD, 6 valve
disease). |
4 weeks | Not matched or
adjusted |
6 |
Azuma et al. 1992 | Cohort:
Physical examination, resting Echo, M-mode Echo. |
CHF patients admitted to cardiac
rehabilitation program (n=34). |
6 weeks | Statement only | 6 |
Azuma et al. 1994 | Cohort
(long-term follow up): Self-reported and physician reported questionnaire of changes in patients’ overall condition. |
CHF patients from 24 study centres
(n=48). |
12 months | No comparison | 5 |
Jeejeebhoy et al. 2002 | Cohort:
NYHA class, blood count, liver and renal biochemistry, radionuclide ventriculography. |
Patients scheduled for elective
aortocoronary bypass surgery with CAD only and a LVEF <=40% (n=41). |
30–40 days | Sex-matched | 6 |
Beyranvand et al. 2011 | Cohort:
Exercise tolerance test (ETT), ECG, HR, BP, serum taurine measure, METS, exercise distance. |
HF due to CAD with a LVEF <50% in
NYHA class II or III (n=29). |
2 weeks | Age-, sex-, and HF
cause-matched |
7 |
Averin et al. 2015 | Cohort:
2D transthoracic echo, Quality of life and psychological status, Lipoproteins, cholesterol, triglycerides. |
CHF patients who have undergone
CPB surgery (n=48). |
3 months | Age-, sex-, HF
cause-matched |
8 |
Shiohira et al. 2015 | Case report:
Echo, dry weight, and blood pressure during HDF. |
HDF patients with CHF in whom dry
weight was difficult to control (n=4; Af, AP, HT, X). |
Varied (not
further described), up to 6 months |
No comparison | 5 |
Azab et al. 2016 | Cohort:
NTproBNP; NYHA class; Echo (not presented). |
CHF patients with document EF
<50% despite successive medical treatment (n=17; 9 DCM; 8 CAD). |
2 months | Age- and sex-
matched |
7 |
Ahmadian
et al. 2017
Ahmadian et al. 2017 (2) |
Cohort:
ECG, Fasting plasma taurine, troponin I, and serum lipoproteins, triglycerides, CRP, and platelet count, METS, exercise distance. |
HF patients due to CAD with a LVEF
<50% (n=16). |
2 weeks | Age- matched | 6–7
(HF cause is described in only one of the papers) |